Literature DB >> 20735884

Concomitants of paranoia in the general population.

D Freeman1, S McManus, T Brugha, H Meltzer, R Jenkins, P Bebbington.   

Abstract

BACKGROUND: Paranoia is an unregarded but pervasive attribute of human populations. In this study we carried out the most comprehensive investigation so far of the demographic, economic, social and clinical correlates of self-reported paranoia in the general population.
METHOD: Data weighted to be nationally representative were analysed from the Adult Psychiatric Morbidity Survey in England (APMS 2007; n=7281).
RESULTS: The prevalence of paranoid thinking in the previous year ranged from 18.6% reporting that people were against them, to 1.8% reporting potential plots to cause them serious harm. At all levels, paranoia was associated with youth, lower intellectual functioning, being single, poverty, poor physical health, poor social functioning, less perceived social support, stress at work, less social cohesion, less calmness, less happiness, suicidal ideation, a great range of other psychiatric symptoms (including anxiety, worry, phobias, post-traumatic stress and insomnia), cannabis use, problem drinking and increased use of treatment and services.
CONCLUSIONS: Overall, the results indicate that paranoia has the widest of implications for health, emotional well-being, social functioning and social inclusion. Some of these concomitants may contribute to the emergence of paranoid thinking, while others may result from it.

Entities:  

Mesh:

Year:  2010        PMID: 20735884     DOI: 10.1017/S0033291710001546

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  65 in total

1.  Is Sleep Health a Potential Pathway to Global Mental Health?

Authors:  Hyong Jin Cho
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

2.  Psychiatric Symptoms, Salivary Cortisol and Cytokine Levels in Young Marijuana Users.

Authors:  Christine C Cloak; Daniel Alicata; Thomas M Ernst; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-15       Impact factor: 4.147

3.  An evolutionary perspective on paranoia.

Authors:  Nichola J Raihani; Vaughan Bell
Journal:  Nat Hum Behav       Date:  2018-12-17

4.  Paranoia as a deficit in non-social belief updating.

Authors:  Erin J Reed; Stefan Uddenberg; Praveen Suthaharan; Christoph D Mathys; Jane R Taylor; Stephanie Mary Groman; Philip R Corlett
Journal:  Elife       Date:  2020-05-26       Impact factor: 8.140

5.  Insomnia, worry, anxiety and depression as predictors of the occurrence and persistence of paranoid thinking.

Authors:  Daniel Freeman; Daniel Stahl; Sally McManus; Howard Meltzer; Traolach Brugha; Nicola Wiles; Paul Bebbington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-09-20       Impact factor: 4.328

6.  The Association between Sleep Problems and Psychotic Symptoms in the General Population: A Global Perspective.

Authors:  Ai Koyanagi; Andrew Stickley
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

7.  Delusions in first-episode psychosis: Principal component analysis of twelve types of delusions and demographic and clinical correlates of resulting domains.

Authors:  Enrico Paolini; Patrizia Moretti; Michael T Compton
Journal:  Psychiatry Res       Date:  2016-06-11       Impact factor: 3.222

Review 8.  Social networks, support and early psychosis: a systematic review.

Authors:  C Gayer-Anderson; C Morgan
Journal:  Epidemiol Psychiatr Sci       Date:  2012-07-26       Impact factor: 6.892

9.  Sleep disturbance and sleep-related impairment in psychotic disorders are related to both positive and negative symptoms.

Authors:  Jack J Blanchard; Alexandra Andrea; Ryan D Orth; Christina Savage; Melanie E Bennett
Journal:  Psychiatry Res       Date:  2020-02-07       Impact factor: 3.222

10.  The relative impact of socioeconomic status and childhood trauma on Black-White differences in paranoid personality disorder symptoms.

Authors:  Juliette M Iacovino; Joshua J Jackson; Thomas F Oltmanns
Journal:  J Abnorm Psychol       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.